As an essential downstream effector of the Wnt signaling pathway, ARL4C upregulated the expression of cyclin D1 and c-myc, thereby affecting the epithelial-mesenchymal transition (EMT) of ccRCC cells. The gene discussed is MYC; the disease is nonpapillary renal cell carcinoma.